CN110772565A - 一种治疗泌尿系结石的中药组合物及其制备方法 - Google Patents
一种治疗泌尿系结石的中药组合物及其制备方法 Download PDFInfo
- Publication number
- CN110772565A CN110772565A CN201810776856.6A CN201810776856A CN110772565A CN 110772565 A CN110772565 A CN 110772565A CN 201810776856 A CN201810776856 A CN 201810776856A CN 110772565 A CN110772565 A CN 110772565A
- Authority
- CN
- China
- Prior art keywords
- parts
- weight
- grass
- chinese medicine
- stone
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 78
- 239000000203 mixture Substances 0.000 title claims abstract description 30
- 238000002360 preparation method Methods 0.000 title claims abstract description 28
- 208000009911 Urinary Calculi Diseases 0.000 title claims abstract description 22
- 206010007027 Calculus urinary Diseases 0.000 title claims description 5
- 239000004575 stone Substances 0.000 claims abstract description 69
- 241000545744 Hirudinea Species 0.000 claims abstract description 33
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 33
- 235000006533 astragalus Nutrition 0.000 claims abstract description 30
- 241001061264 Astragalus Species 0.000 claims abstract description 28
- 241000241125 Gryllotalpa gryllotalpa Species 0.000 claims abstract description 28
- 210000004233 talus Anatomy 0.000 claims abstract description 28
- 241000218671 Ephedra Species 0.000 claims abstract description 27
- 241000931191 Scincidae Species 0.000 claims abstract description 26
- 241000202726 Bupleurum Species 0.000 claims abstract description 25
- 235000006679 Mentha X verticillata Nutrition 0.000 claims abstract description 25
- 235000002899 Mentha suaveolens Nutrition 0.000 claims abstract description 25
- 235000001636 Mentha x rotundifolia Nutrition 0.000 claims abstract description 25
- 235000001155 Setaria leucopila Nutrition 0.000 claims abstract description 25
- 241000820163 Setaria leucopila Species 0.000 claims abstract description 25
- 235000006040 Prunus persica var persica Nutrition 0.000 claims abstract description 23
- 241000427159 Achyranthes Species 0.000 claims abstract description 17
- 240000000249 Morus alba Species 0.000 claims abstract description 17
- 235000008708 Morus alba Nutrition 0.000 claims abstract description 17
- 244000144730 Amygdalus persica Species 0.000 claims abstract description 15
- 235000012469 Cleome gynandra Nutrition 0.000 claims abstract description 15
- 244000227271 Cleome gynandra Species 0.000 claims abstract description 14
- 244000025254 Cannabis sativa Species 0.000 claims abstract description 13
- 240000002853 Nelumbo nucifera Species 0.000 claims abstract description 12
- 235000006508 Nelumbo nucifera Nutrition 0.000 claims abstract description 12
- 235000006510 Nelumbo pentapetala Nutrition 0.000 claims abstract description 12
- 239000002994 raw material Substances 0.000 claims abstract description 9
- 241000283690 Bos taurus Species 0.000 claims abstract description 6
- 239000000843 powder Substances 0.000 claims description 38
- 239000000284 extract Substances 0.000 claims description 18
- 235000009508 confectionery Nutrition 0.000 claims description 16
- 235000013399 edible fruits Nutrition 0.000 claims description 16
- 239000007788 liquid Substances 0.000 claims description 13
- 238000000034 method Methods 0.000 claims description 13
- 239000000463 material Substances 0.000 claims description 10
- 239000000706 filtrate Substances 0.000 claims description 9
- 240000005809 Prunus persica Species 0.000 claims description 8
- 241000372906 Vahlodea Species 0.000 claims description 8
- 240000006054 Agastache cana Species 0.000 claims description 7
- 241000282326 Felis catus Species 0.000 claims description 7
- 235000010650 Hyssopus officinalis Nutrition 0.000 claims description 7
- 239000004576 sand Substances 0.000 claims description 7
- 239000000725 suspension Substances 0.000 claims description 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 6
- 244000197975 Solidago virgaurea Species 0.000 claims description 4
- 235000000914 Solidago virgaurea Nutrition 0.000 claims description 4
- 210000003127 knee Anatomy 0.000 claims description 4
- 241000735432 Hydrastis canadensis Species 0.000 claims description 3
- 239000012141 concentrate Substances 0.000 claims description 3
- 239000003937 drug carrier Substances 0.000 claims description 3
- 235000005679 goldenseal Nutrition 0.000 claims description 3
- 244000309464 bull Species 0.000 claims description 2
- 241000045403 Astragalus propinquus Species 0.000 claims 2
- 235000003840 Amygdalus nana Nutrition 0.000 claims 1
- 241000628997 Flos Species 0.000 claims 1
- 241000234435 Lilium Species 0.000 claims 1
- 241000203475 Neopanax arboreus Species 0.000 claims 1
- 241000220299 Prunus Species 0.000 claims 1
- 235000011432 Prunus Nutrition 0.000 claims 1
- 244000184734 Pyrus japonica Species 0.000 claims 1
- 244000076686 Queensland pidgeon grass Species 0.000 claims 1
- 235000003232 Setaria pumila ssp. pallide fusca Nutrition 0.000 claims 1
- 235000014774 prunus Nutrition 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 23
- 208000024891 symptom Diseases 0.000 abstract description 22
- 229940079593 drug Drugs 0.000 abstract description 19
- 231100000957 no side effect Toxicity 0.000 abstract description 7
- 230000008901 benefit Effects 0.000 abstract description 6
- 241000196324 Embryophyta Species 0.000 abstract description 4
- 241001465754 Metazoa Species 0.000 abstract description 4
- 239000013589 supplement Substances 0.000 abstract description 3
- 241000282898 Sus scrofa Species 0.000 abstract 1
- 210000004369 blood Anatomy 0.000 description 27
- 239000008280 blood Substances 0.000 description 27
- 210000004185 liver Anatomy 0.000 description 22
- 208000002193 Pain Diseases 0.000 description 21
- 210000003734 kidney Anatomy 0.000 description 13
- 230000027939 micturition Effects 0.000 description 13
- 238000002604 ultrasonography Methods 0.000 description 13
- 210000003932 urinary bladder Anatomy 0.000 description 11
- 230000007812 deficiency Effects 0.000 description 10
- 210000002700 urine Anatomy 0.000 description 10
- 206010013990 dysuria Diseases 0.000 description 9
- 210000004072 lung Anatomy 0.000 description 9
- 210000000952 spleen Anatomy 0.000 description 9
- 206010030113 Oedema Diseases 0.000 description 8
- 238000009825 accumulation Methods 0.000 description 8
- 208000004998 Abdominal Pain Diseases 0.000 description 7
- 210000001624 hip Anatomy 0.000 description 7
- 239000003826 tablet Substances 0.000 description 7
- 208000004880 Polyuria Diseases 0.000 description 6
- 230000003187 abdominal effect Effects 0.000 description 6
- 230000035619 diuresis Effects 0.000 description 6
- 201000007227 lymph node tuberculosis Diseases 0.000 description 6
- 208000008035 Back Pain Diseases 0.000 description 5
- 206010011224 Cough Diseases 0.000 description 5
- 206010020524 Hydronephrosis Diseases 0.000 description 5
- 208000000913 Kidney Calculi Diseases 0.000 description 5
- 206010029148 Nephrolithiasis Diseases 0.000 description 5
- 206010042674 Swelling Diseases 0.000 description 5
- 208000006568 Urinary Bladder Calculi Diseases 0.000 description 5
- 210000001015 abdomen Anatomy 0.000 description 5
- 210000000988 bone and bone Anatomy 0.000 description 5
- 239000002775 capsule Substances 0.000 description 5
- 239000011248 coating agent Substances 0.000 description 5
- 238000000576 coating method Methods 0.000 description 5
- 238000003745 diagnosis Methods 0.000 description 5
- 239000002934 diuretic Substances 0.000 description 5
- 230000001882 diuretic effect Effects 0.000 description 5
- 238000000605 extraction Methods 0.000 description 5
- 206010016256 fatigue Diseases 0.000 description 5
- 230000008961 swelling Effects 0.000 description 5
- 208000008930 Low Back Pain Diseases 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 238000002309 gasification Methods 0.000 description 4
- 239000008187 granular material Substances 0.000 description 4
- 208000006750 hematuria Diseases 0.000 description 4
- 241000411851 herbal medicine Species 0.000 description 4
- 238000002156 mixing Methods 0.000 description 4
- 210000003205 muscle Anatomy 0.000 description 4
- 210000003800 pharynx Anatomy 0.000 description 4
- 238000004080 punching Methods 0.000 description 4
- 208000011580 syndromic disease Diseases 0.000 description 4
- 210000000626 ureter Anatomy 0.000 description 4
- 208000008281 urolithiasis Diseases 0.000 description 4
- 208000006820 Arthralgia Diseases 0.000 description 3
- 208000002881 Colic Diseases 0.000 description 3
- 206010012735 Diarrhoea Diseases 0.000 description 3
- 241001243087 Gryllotalpidae Species 0.000 description 3
- 206010062717 Increased upper airway secretion Diseases 0.000 description 3
- 206010037660 Pyrexia Diseases 0.000 description 3
- 230000003213 activating effect Effects 0.000 description 3
- 239000000654 additive Substances 0.000 description 3
- 239000002671 adjuvant Substances 0.000 description 3
- 230000001476 alcoholic effect Effects 0.000 description 3
- 230000009286 beneficial effect Effects 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 230000017531 blood circulation Effects 0.000 description 3
- 208000002173 dizziness Diseases 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 239000000796 flavoring agent Substances 0.000 description 3
- 235000013355 food flavoring agent Nutrition 0.000 description 3
- 230000001976 improved effect Effects 0.000 description 3
- 201000004792 malaria Diseases 0.000 description 3
- 230000003211 malignant effect Effects 0.000 description 3
- 239000002398 materia medica Substances 0.000 description 3
- 208000026435 phlegm Diseases 0.000 description 3
- 239000006187 pill Substances 0.000 description 3
- 238000001556 precipitation Methods 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 230000001105 regulatory effect Effects 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- 238000005728 strengthening Methods 0.000 description 3
- 230000035900 sweating Effects 0.000 description 3
- 210000003708 urethra Anatomy 0.000 description 3
- 210000001835 viscera Anatomy 0.000 description 3
- 239000008916 wei-ling-xian Substances 0.000 description 3
- 239000009654 wuzhi Substances 0.000 description 3
- LQIAZOCLNBBZQK-UHFFFAOYSA-N 1-(1,2-Diphosphanylethyl)pyrrolidin-2-one Chemical compound PCC(P)N1CCCC1=O LQIAZOCLNBBZQK-UHFFFAOYSA-N 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- 206010007247 Carbuncle Diseases 0.000 description 2
- 206010008469 Chest discomfort Diseases 0.000 description 2
- 208000034656 Contusions Diseases 0.000 description 2
- 206010012335 Dependence Diseases 0.000 description 2
- 208000010201 Exanthema Diseases 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 201000007100 Pharyngitis Diseases 0.000 description 2
- 208000012287 Prolapse Diseases 0.000 description 2
- 244000269722 Thea sinensis Species 0.000 description 2
- 206010047700 Vomiting Diseases 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 235000013334 alcoholic beverage Nutrition 0.000 description 2
- 230000036528 appetite Effects 0.000 description 2
- 235000019789 appetite Nutrition 0.000 description 2
- 208000006673 asthma Diseases 0.000 description 2
- 230000002146 bilateral effect Effects 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 244000309466 calf Species 0.000 description 2
- 235000008504 concentrate Nutrition 0.000 description 2
- 230000003750 conditioning effect Effects 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 230000008021 deposition Effects 0.000 description 2
- 210000003743 erythrocyte Anatomy 0.000 description 2
- 201000005884 exanthem Diseases 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 210000003414 extremity Anatomy 0.000 description 2
- 239000012467 final product Substances 0.000 description 2
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 2
- 235000013376 functional food Nutrition 0.000 description 2
- 208000022182 gross hematuria Diseases 0.000 description 2
- 230000001965 increasing effect Effects 0.000 description 2
- 238000001802 infusion Methods 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 238000001990 intravenous administration Methods 0.000 description 2
- 210000000244 kidney pelvis Anatomy 0.000 description 2
- 239000000314 lubricant Substances 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 210000004061 pubic symphysis Anatomy 0.000 description 2
- 238000010298 pulverizing process Methods 0.000 description 2
- 206010037844 rash Diseases 0.000 description 2
- 239000005871 repellent Substances 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 239000003381 stabilizer Substances 0.000 description 2
- 238000010025 steaming Methods 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- 230000001256 tonic effect Effects 0.000 description 2
- 210000003905 vulva Anatomy 0.000 description 2
- 238000005550 wet granulation Methods 0.000 description 2
- 206010003445 Ascites Diseases 0.000 description 1
- 206010063659 Aversion Diseases 0.000 description 1
- 206010004446 Benign prostatic hyperplasia Diseases 0.000 description 1
- 206010009866 Cold sweat Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 206010014080 Ecchymosis Diseases 0.000 description 1
- 206010051267 Facial paresis Diseases 0.000 description 1
- 208000015220 Febrile disease Diseases 0.000 description 1
- 208000036119 Frailty Diseases 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 201000005569 Gout Diseases 0.000 description 1
- 206010019468 Hemiplegia Diseases 0.000 description 1
- 241000521257 Hydrops Species 0.000 description 1
- 206010020710 Hyperphagia Diseases 0.000 description 1
- 206010020850 Hyperthyroidism Diseases 0.000 description 1
- 208000004044 Hypesthesia Diseases 0.000 description 1
- 241000483399 Ipimorpha retusa Species 0.000 description 1
- GSDSWSVVBLHKDQ-JTQLQIEISA-N Levofloxacin Chemical compound C([C@@H](N1C2=C(C(C(C(O)=O)=C1)=O)C=C1F)C)OC2=C1N1CCN(C)CC1 GSDSWSVVBLHKDQ-JTQLQIEISA-N 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 208000037093 Menstruation Disturbances Diseases 0.000 description 1
- 206010027339 Menstruation irregular Diseases 0.000 description 1
- 244000246386 Mentha pulegium Species 0.000 description 1
- 235000016257 Mentha pulegium Nutrition 0.000 description 1
- 235000004357 Mentha x piperita Nutrition 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- 208000007101 Muscle Cramp Diseases 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 206010030302 Oliguria Diseases 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 241000238814 Orthoptera Species 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- 240000004371 Panax ginseng Species 0.000 description 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 208000004403 Prostatic Hyperplasia Diseases 0.000 description 1
- 235000013999 Prunus japonica Nutrition 0.000 description 1
- 241000392950 Prunus japonica Species 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 206010037549 Purpura Diseases 0.000 description 1
- 206010038419 Renal colic Diseases 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 208000004078 Snake Bites Diseases 0.000 description 1
- 206010043376 Tetanus Diseases 0.000 description 1
- FNYLWPVRPXGIIP-UHFFFAOYSA-N Triamterene Chemical compound NC1=NC2=NC(N)=NC(N)=C2N=C1C1=CC=CC=C1 FNYLWPVRPXGIIP-UHFFFAOYSA-N 0.000 description 1
- 208000004608 Ureteral Obstruction Diseases 0.000 description 1
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 1
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 1
- 206010046814 Uterine prolapse Diseases 0.000 description 1
- 206010047601 Vitamin B1 deficiency Diseases 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 208000019790 abdominal distention Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 238000002583 angiography Methods 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000002518 antifoaming agent Substances 0.000 description 1
- 210000000436 anus Anatomy 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 208000002894 beriberi Diseases 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 230000033558 biomineral tissue development Effects 0.000 description 1
- 229910052797 bismuth Inorganic materials 0.000 description 1
- JCXGWMGPZLAOME-UHFFFAOYSA-N bismuth atom Chemical compound [Bi] JCXGWMGPZLAOME-UHFFFAOYSA-N 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 235000008429 bread Nutrition 0.000 description 1
- 229960004755 ceftriaxone Drugs 0.000 description 1
- VAAUVRVFOQPIGI-SPQHTLEESA-N ceftriaxone Chemical compound S([C@@H]1[C@@H](C(N1C=1C(O)=O)=O)NC(=O)\C(=N/OC)C=2N=C(N)SC=2)CC=1CSC1=NC(=O)C(=O)NN1C VAAUVRVFOQPIGI-SPQHTLEESA-N 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 229940112822 chewing gum Drugs 0.000 description 1
- 235000015218 chewing gum Nutrition 0.000 description 1
- 201000001883 cholelithiasis Diseases 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 208000035850 clinical syndrome Diseases 0.000 description 1
- 238000009535 clinical urine test Methods 0.000 description 1
- 239000000571 coke Substances 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 238000013270 controlled release Methods 0.000 description 1
- 238000010411 cooking Methods 0.000 description 1
- 201000003146 cystitis Diseases 0.000 description 1
- 238000002574 cystoscopy Methods 0.000 description 1
- 235000021185 dessert Nutrition 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 229940042399 direct acting antivirals protease inhibitors Drugs 0.000 description 1
- 239000007884 disintegrant Substances 0.000 description 1
- 239000002270 dispersing agent Substances 0.000 description 1
- 239000008298 dragée Substances 0.000 description 1
- 206010013781 dry mouth Diseases 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 235000006694 eating habits Nutrition 0.000 description 1
- 230000002996 emotional effect Effects 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 208000010770 facial weakness Diseases 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 238000005187 foaming Methods 0.000 description 1
- 239000004088 foaming agent Substances 0.000 description 1
- 210000002683 foot Anatomy 0.000 description 1
- 235000020510 functional beverage Nutrition 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 208000001130 gallstones Diseases 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 208000021760 high fever Diseases 0.000 description 1
- 235000001050 hortel pimenta Nutrition 0.000 description 1
- 208000006278 hypochromic anemia Diseases 0.000 description 1
- 208000034783 hypoesthesia Diseases 0.000 description 1
- 238000003384 imaging method Methods 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 229960001936 indinavir Drugs 0.000 description 1
- CBVCZFGXHXORBI-PXQQMZJSSA-N indinavir Chemical compound C([C@H](N(CC1)C[C@@H](O)C[C@@H](CC=2C=CC=CC=2)C(=O)N[C@H]2C3=CC=CC=C3C[C@H]2O)C(=O)NC(C)(C)C)N1CC1=CC=CN=C1 CBVCZFGXHXORBI-PXQQMZJSSA-N 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 206010022000 influenza Diseases 0.000 description 1
- 208000030603 inherited susceptibility to asthma Diseases 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 229960003376 levofloxacin Drugs 0.000 description 1
- 239000008876 liujunzi Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 210000004705 lumbosacral region Anatomy 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 208000018962 mouth sore Diseases 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 201000008383 nephritis Diseases 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 206010029410 night sweats Diseases 0.000 description 1
- 230000036565 night sweats Effects 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 229940126701 oral medication Drugs 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 235000020830 overeating Nutrition 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 239000003961 penetration enhancing agent Substances 0.000 description 1
- 239000000137 peptide hydrolase inhibitor Substances 0.000 description 1
- 206010034754 petechiae Diseases 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 230000007096 poisonous effect Effects 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000002601 radiography Methods 0.000 description 1
- 210000000664 rectum Anatomy 0.000 description 1
- 230000000306 recurrent effect Effects 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 230000000552 rheumatic effect Effects 0.000 description 1
- 206010039073 rheumatoid arthritis Diseases 0.000 description 1
- 201000005404 rubella Diseases 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 208000013220 shortness of breath Diseases 0.000 description 1
- 208000011726 slow pulse Diseases 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000007940 sugar coated tablet Substances 0.000 description 1
- 229940124530 sulfonamide Drugs 0.000 description 1
- 150000003456 sulfonamides Chemical class 0.000 description 1
- 239000000829 suppository Substances 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 239000000375 suspending agent Substances 0.000 description 1
- 238000013268 sustained release Methods 0.000 description 1
- 239000012730 sustained-release form Substances 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 206010044008 tonsillitis Diseases 0.000 description 1
- 208000004371 toothache Diseases 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 108700012359 toxins Proteins 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 229960001288 triamterene Drugs 0.000 description 1
- 201000008827 tuberculosis Diseases 0.000 description 1
- 210000000689 upper leg Anatomy 0.000 description 1
- 201000009160 urethral calculus Diseases 0.000 description 1
- 229940116269 uric acid Drugs 0.000 description 1
- 230000002485 urinary effect Effects 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
- A61K35/64—Insects, e.g. bees, wasps or fleas
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/58—Reptiles
- A61K35/583—Snakes; Lizards, e.g. chameleons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/62—Leeches; Worms, e.g. cestodes, tapeworms, nematodes, roundworms, earth worms, ascarids, filarias, hookworms, trichinella or taenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/11—Pteridophyta or Filicophyta (ferns)
- A61K36/12—Filicopsida or Pteridopsida
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/17—Gnetophyta, e.g. Ephedraceae (Mormon-tea family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/21—Amaranthaceae (Amaranth family), e.g. pigweed, rockwort or globe amaranth
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/233—Bupleurum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/534—Mentha (mint)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/69—Polygalaceae (Milkwort family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
- A61K36/716—Clematis (leather flower)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/04—Drugs for disorders of the urinary system for urolithiasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Insects & Arthropods (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Animal Husbandry (AREA)
- Urology & Nephrology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Tropical Medicine & Parasitology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明属于中医药领域,具体为一种治疗泌尿系结石的中药组合物及其制备方法。所述中药组合物由下述原料组分制备而成:金沙牛、石龙子、水蛭、蝼蛄、柴胡、麻黄、猪鬃草、薄荷、猫须草、穿破石、威灵仙、楮实子、黄芪、黄花倒水莲、五指毛桃、牛膝。本发明组方攻补兼备,标本兼治,动植物结合,升降同用,疗效高,药源丰富,价格低廉,无副作用,具有疗效好、见效快、无副作用、治疗成本低、制备方法简单的优点。
Description
【技术领域】
本发明涉及中医药领域,具体涉及一种治疗泌尿系结石的中药组合物及其制备方法。
【背景技术】
泌尿系结石也称为尿石症,是指在泌尿系统内因尿液浓缩沉淀形成颗粒或成块样聚集物,包括肾结石,输尿管结石,膀胱结石,尿道结石,最常见的就是肾结石与输尿管结石,大多数是由于尿液中的物质在各种因素的影响下,沉积、析出而形成的,是一种人体异常矿物质化的结果,大多数尿结石含有钙,在X线片上能看到,叫阳性结石,少数结石如奶粉事件中的结石是尿酸结石,它还有服药不当(如磺胺类药物、碱性类药物,钙、镁、铋类,头孢曲松钠,氨苯蝶啶,蛋白酶抑制剂包括茚地那韦等)在X线片上看不到,就叫阴性结石。科学家发现肥胖、糖尿病、骨质疏松、长期卧床、甲状膀腺功能亢进病人非常容易患结石病,是结石的易感因素。老年人排尿困难,前列腺增生,排尿不净,也是发生膀胱结石的原因。
中医认为,本病属中医学“石淋”、“腰痛”范畴。尿路结石的形成主要是由于下焦湿热蕴结,煎熬津液,尿液受其煎熬,尿中杂质析出,沉积于肾、输尿管或膀胱而形成结石。这与当地土壤盐碱度,水质成分以及患者饮食习惯密切相关,过食辛辣油腻饮食常为其诱因。湿热内生,热壅血瘀,尿道不畅则尿频、尿急、尿痛发作;湿热蕴结,灼伤血脉,血溢脉外,则尿血;结石形成以后,阻塞尿道,水液不能下行,出现结石嵌顿,尿液下流受阻,水湿停聚则形成肾积水,局部有水肿、炎性粘连等病变。结石既是病理产物也是致病因素,结石的发病机理是湿热阻滞,气机不利,血脉瘀积。
目前,社会上治疗泌尿结石病,西医是采用手术取石或碎石机碎石,中医大多采用清热化湿,利水通淋,溶石止痛的三金为主药的中药配方,这样做往往能够排石出来,但是这样治疗往往是治标不治本,反复发作。一些老年人泌尿系统结石,久服通利致虚者,或者有些病人治好了结石,过了不久又得了结石;有些人手术取出了结石,又反复地长出结石,或者体外震碎石后残石遗留者,都是因为:虽然结石不见了,但是致病的病因没有彻底消除,病人的体质没有恢复到健康水平的缘故。对于这种顽固结石,清·尤在径提出了“开郁行气,破血滋阴”一法,根据这一理论,本发明从气机调节入手配方,结合升阳补气、破血溶石、通淋利水,有效纠正脏腑功能的失调和代谢的紊乱,使机体气血、阴阳归于平衡,达到治愈结石的目的。
【发明内容】
本发明的发明目的在于:针对现有技术的不足,提供一种治疗泌尿系结石的中药组合物及其制备方法,本发明组方攻补兼备,标本兼治,动植物结合,升降同用,疗效高,药源丰富,价格低廉,无副作用,具有疗效好、见效快、无副作用、治疗成本低、制备方法简单的优点。
为了实现上述目的,本发明采用的技术方案如下:
一种治疗泌尿系结石的中药组合物,由下述原料组分制备而成:金沙牛、石龙子、水蛭、蝼蛄、柴胡、麻黄、猪鬃草、薄荷、猫须草、穿破石、威灵仙、楮实子、黄芪、黄花倒水莲、五指毛桃、牛膝。
进一步地,由下述原料组分制备而成:金沙牛3~8重量份、石龙子3~8重量份、水蛭3~8重量份、蝼蛄3~8重量份、柴胡5~15重量份、麻黄3~8重量份、猪鬃草30~50重量份、薄荷30~50重量份、猫须草30~50重量份、穿破石10~20重量份、威灵仙10~20重量份、楮实子10~20重量份、黄芪20~40重量份、黄花倒水莲20~40重量份、五指毛桃20~40重量份、牛膝10~20重量份。
优选地,由下述原料组分制备而成:金沙牛5重量份、石龙子5重量份、水蛭5重量份、蝼蛄5重量份、柴胡10重量份、麻黄5重量份、猪鬃草40重量份、薄荷40重量份、猫须草40重量份、穿破石15重量份、威灵仙15重量份、楮实子15重量份、黄芪30重量份、黄花倒水莲30重量份、五指毛桃30重量份、牛膝15重量份。
本发明所述中药组合物的制备方法,包括以下步骤:
(1)将金沙牛、水蛭、石龙子和蝼蛄烘干粉碎成药粉;
(2)将猪鬃草、猫须草、穿破石、威灵仙、楮实子、黄芪、黄花倒水莲、五指毛桃、牛膝、柴胡、麻黄用甜酒水浸泡,然后煎煮1~3次,每次1~3小时;合并药液,加入薄荷煮沸5~10分钟,过滤;取滤液浓缩成浸膏,将浸膏和步骤(1)得到的金沙牛,石龙子,水蛭,蝼蛄药粉混合均匀,即得。
进一步地,步骤(2)中,先将猪鬃草、猫须草、穿破石、威灵仙、楮实子、黄芪、黄花倒水莲、五指毛桃、牛膝、柴胡、麻黄粉粹成药材粗粉;向所述药材粗粉加入3~10倍重量的甜酒水,混匀得混悬液,浸泡24小时后煎煮3次,每次1小时,合并药液,加入薄荷煮沸5~10分钟,过滤,取滤液浓缩成浸膏,将浸膏和步骤(1)得到的金沙牛,石龙子,水蛭,蝼蛄药粉混合均匀,即得。
进一步地,所述甜酒水的酒精度数为15%~20%。
本发明还提供了一种治疗泌尿系结石的中药制剂,其由上述中药组合物单独制成或由上述中药组合物和药学上可接受的载体组成。
其中,上述中药组合物与适当的药学上可接受的载体(辅料或辅助性成分)混合后,按照常规的产品制备方法,可以制备成治疗泌尿系结石的产品。
例如:
1、在医药领域:与在口服制剂中可以被接受的崩解剂、赋形剂、润滑剂、粘合剂、填充剂等常用辅助添加成分混合后,按常规的操作方法和过程,可以制成片剂、丸剂、胶囊剂、颗粒剂或多种相应的缓释剂、控释剂等固体口服制剂形式的药物;与常规的基质、表面活性剂、穿透促进剂等常用辅助添加成分混合后,按常规的操作方法和过程,可以制成外用膏剂、栓剂、胶剂等半固体制剂形式的药物。与常规的增溶剂、乳化剂、润滑剂、起泡或消泡剂等表面活性剂、稀释剂、防腐剂、稳定剂、矫味剂、增稠剂等混合后,按相应的常规方法,可以制备成水剂、糖浆、口服液等液体制剂形式的口服药物;与常规的悬浮剂、稳定剂、分散剂或调节溶液渗透压的试剂混合,按相应的常规方法,配置成注射液、粉针剂等注射用制剂。
2、在功能食品领域:与常用辅助添加成分混合后,按常规的操作方法和过程,可以制成面包、功能饮料、保健茶、口香糖等形式的功能食品。
本发明还提供了上述中药组合物或制剂在制备治疗泌尿系结石药物中的应用。
本发明所用的原料来源如下:
(1)金沙牛:味辛,咸,性温;入肾、膀胱经。通窍利水。《本草纲目》记载:“散结,利尿通淋,化疔毒;主小儿高热,肾及尿道结石,小便不利,瘰疬,疔疮。
(2)石龙子:咸,温。破结,行水。治小便不利,石淋,恶疮瘰疬,臁疮。《本经逢原》
(3)水蛭:咸苦,平;入肝、膀胱经。活血通经,散瘀消瘕。主治逐恶血、瘀血、月闭,破血瘕积聚,无子,利水道。《本经》
(4)蝼蛄:咸、寒、无毒。归膀胱、大肠、小肠经。利水通淋,消肿解毒。主治利大小便,通石淋,治瘰疬,骨鲠。《本草纲目》
(5)猪鬃草:淡、苦,凉。入肝肾二经。清热解毒,利湿消肿,利尿通淋。用于痢疾,瘰疬,肺热咳嗽,肝炎,尿路结石,毒蛇咬伤,跌打损伤。《云南中草药选》
(6)薄荷:辛,凉。入肺经、肝经。疏散风热,清利头目,利咽透疹,疏肝行气。、瘾疹、温病初起、风疹瘙痒、肝郁气滞、胸闷胁痛。
(7)猫须草,又叫化石草,在我国西南地区民间常作排石药使用;甘淡、微苦,凉。清热去湿,排石利水。主治:治急性肾炎,膀胱炎,尿路结石,风湿性关节炎。《全国中草药汇编》。
(8)穿破石:性凉,味淡、微苦。归心经、肝经。破血通经。主治:淋浊,去远年瘀积、结石。《南宁市药物志》
(9)威灵仙:辛咸,温,有毒。入膀胱经。祛风湿,通经络,消痰涎,散癖积。治痛风、顽痹、腰膝冷痛,脚气,疟疾,胆结石,症瘕积聚,破伤风,扁桃体炎,诸骨鲠咽。
(10)楮实子:甘,寒。入肝,脾、肾经。壮筋骨,助阳气,补虚劳,助腰膝,益颜色。主治:腰膝酸软、虚劳骨蒸、砂晕目昏、目生翳膜、水肿胀满。《日华子本草》
(11)黄芪:甘,微温。归肺、脾、肝、肾经。补气升阳、固表止汗、排脓生肌、消肿利尿。主治;用于气虚乏力,食少便溏,中气下陷,久泻脱肛,便血崩漏,表虚自汗,气虚水肿,内热消渴,血虚萎黄,半身不遂,痹痛麻木,痈疽难溃,久溃不敛。
(12)五指毛桃:辛,甘,温。入脾、肺、肝经。益气补虚、行气解郁、壮筋活络、健脾化湿、止咳化痰等功效。用于脾虚浮肿,食少无力,肺痨咳嗽,盗汗,风湿痹痛,产后无乳。《广西民间常用草药手册》
(13)黄花倒水莲:甘,微苦;性平,归经,肝;肾;脾经。补益,强壮,祛湿,散瘀。用于补气血,壮筋骨,治病后虚弱,产后血虚,脾虚水肿《广西中草药》。
(14)牛膝:味苦、酸,性平。归肝、肾经。活血祛瘀,补肝肾,强筋骨,引血下行,利尿通淋。《纲目》:"治久疟寒热,五淋尿血,茎中痛,下痢,喉痹,口疮,齿痛,痈肿恶疮,伤折。
(15)柴胡:性味苦、微寒,归肝、胆经。和解表里,疏肝升阳。用于感冒发热、寒热往来、疟疾、肝郁气滞、胸肋胀痛、脱肛、子宫脱垂、月经不调。
(16)麻黄:辛、微苦,温。肺经、膀胱经。发汗解表,宣肺平喘,利水消肿。可治疗风寒感冒、胸闷喘咳、风水浮肿、支气管哮喘等病症。
(17)甜酒水:(即醪槽汁水,略具酒性),酒性开散,有助于气化,或可扩张尿道,并可推动药力。同时,用甜酒水作为提取溶剂,既有利于提高药物提取率,也可作药剂调味剂,使口感更加符合人性化。
综上所述,由于采用了上述技术方案,本发明的有益效果是:
本发明的一种治疗泌尿系结石的中药组合物,由主药、副药、佐药和使药在使用时煎煮而成,其配伍关系如下:
主药由猪鬃草、猫须草和薄荷组成,猫须草,又叫化石草,在我国西南地区民间常作排石药使用;猪鬃草为铁线厥科植物,药用全草,主要用于感冒发热,肺热咳嗽。其活血化瘀,去瘀生新,药书多载其治疗风湿病和跌打损伤,其实为贵州一草医治疗泌尿系结石的秘方,见于《石恩骏临床经验集》。薄荷则是非常普遍的中药,主治风热感冒咽喉肿痛等。试观炊壶烧水沏茗,无论水质多优,数月之内壶内四壁必附一层石垢,其硬如石,以薄荷100克放入壶内煮沸,如石之物顿时溶为糊状而脱落。从烧水工常用此法,联想到人体结石亦有类似之处,且薄荷未见伤身之大碍,故用之于人屡用屡验,历代药书未见其治结石的记载,今仅见于四川白习明老中医的《中医临证求索集》。猫须草、猪鬃草、薄荷均是民间溶石排石的草药组,作为本方的主药。
副药由金沙牛、石龙子、蝼蛄组成,金沙牛是我国南方地区传统的溶石药,历史悠久。而石龙子平常多用于癫痫、恶疮瘰疬、肿瘤等,蝼蛄则常作为利水药,用于水肿、腹水等。沙牛、石龙子、蝼蛄三种动物药组走窜迅猛,都具有利水通淋化石作用,能加强主药的作用。
佐药由穿破石、威灵仙、楮实子、黄芪、水蛭、黄花倒水莲、五指毛桃、牛膝、麻黄和柴胡组成,威灵仙走十二经络,最能散结癖积,还能化诸骨鲠咽;它和楮实子组成化铁丸化坚散结,治疗一切难化坚硬的肿物和结石。穿破石,岭南又叫黄鸡脚,是岭南传统治疗结石用药,它茎上带刺,它的攻坚性很好,对肝硬化、乳腺增生和子宫肌瘤常用。楮实子和威灵仙药对组成化铁丸,此外,它能平补肝,脾、肾阴,仿增液行舟之意,以防利水太过之害。穿破石、威灵仙、楮实子作为攻坚破瘀药组,与主药相须为用;柴胡入肝经,能疏肝升阳,肝郁气滞。五指毛桃也有入肝经,行气解郁。柴胡、五指毛桃都能行气解郁,作为疏肝理脾调气机药组,能加强主药的作用;黄芪和柴胡,则是一对升阳调气药,如著名的补中益气丸中就此药对,它起到升阳补气的作用。黄芪有补益元气、扶正培本之功;水蛭,俗称蚂蟥,是一种破血通经中药。黄芪以补气为主,水蛭以通为要,黄芪和水蛭相伍,一补气,一行血,一补一通,君臣合参,二者相和。牛膝有引血下行,利尿通淋之功,与黄芪主升形成一升一降,升降相因,有助于排出结石。黄芪、水蛭和牛膝同用,行气活血,化瘀止痛,升降同用,消补并用,相辅相成,在本方中起到加强主药的作用;五指毛桃、黄花倒水莲是瑶族传统滋补药对,黄芪、五指毛桃、黄花倒水莲的组成补气药组,从而形成在脏腑中强大的推动力。欲使结石下移,必将使中气上提,故此方用大剂量补气药补益中气,在此活血行气、升阳补气的基础上,配伍利水通淋、攻坚排石之药,升降荡涤,调节气机,激活气血,振奋脏腑功能,可使结石溶解下移,排出体外。“气为血之帅”,本方中使用大量的补气药的意义在于:它不仅提供调节气机的动力,排除结石;还在于纠正利通攻伐中对身体可能造成的影响,更重要的在于滋补身体,增强体质,防止结石复发,本组药物能加强主药的作用;
使药由麻黄和甜酒水组成。麻黄轻清上浮,专疏肺郁,宣泄气机,是为治感第一要药,虽曰解表,实为开肺,虽曰散寒,实为泄邪,风寒固得之而外散,即温热亦无不赖之以宣通。麻黄在本方中用于治疗泌尿系结石仍是借其宣肺之力,俾膀胱气化,结石得以下降,类似提壶揭盖的作用。麻黄是中空之物,宛如管腔,彻上彻下,使上焦能通,中焦能行,下焦能利,三焦上下通气形成一股气流,麻黄作为引经药起到使药作用;甜酒水(即醪槽汁水,略具酒性),酒性开散,有助于气化,或可扩张尿道,并可推动药力。同时,用甜酒水作为提取溶剂,既有利于提高药物提取率,也可作药剂调味剂,使口感更加符合人性化。
本发明是在传统中医理论和临床经验指导下,并结合祖传秘方和民间土方,精选出各原料药及其配比,达到升降气机、调和气血、清热利湿、攻坚排石的功效。
本发明组方攻补兼备,标本兼治,动植物结合,升降同用,疗效高,药源丰富,价格低廉,无副作用,具有疗效好、见效快、无副作用、治疗成本低、制备方法简单的优点。在临床实验中,2个疗程临床治疗泌尿系结石,治愈率达95%以上,且患者在排石的过程无明显痛苦。
【具体实施方式】
实施例1
处方:金沙牛5g、石龙子5g、水蛭5g、蝼蛄5g、柴胡10g、麻黄5g、猪鬃草40g、薄荷40g、猫须草40g、穿破石15g、威灵仙15g、楮实子15g、黄芪30g、黄花倒水莲30g、五指毛桃30g、牛膝15g。
制法:(1)将金沙牛、水蛭、石龙子和蝼蛄烘干粉碎成药粉;
(2)将猪鬃草、猫须草、穿破石、威灵仙、楮实子、黄芪、黄花倒水莲、五指毛桃、牛膝、柴胡、麻黄粉粹成药材粗粉;向所述药材粗粉加入6倍重量的酒精度数为18%的甜酒水,混匀得混悬液,浸泡24小时后煎煮2次,每次2小时,合并药液,加入薄荷煮沸8分钟,过滤,取滤液浓缩成浸膏,将浸膏和步骤(1)得到的金沙牛,石龙子,水蛭,蝼蛄药粉混合均匀,即得。
实施例2
处方:金沙牛5g、石龙子5g、水蛭5g、蝼蛄5g、柴胡10g、麻黄5g、猪鬃草40g、薄荷40g、猫须草40g、穿破石15g、威灵仙15g、楮实子15g、黄芪30g、黄花倒水莲30g、五指毛桃30g、牛膝15g。
制法:
(1)将金沙牛、水蛭、石龙子和蝼蛄烘干粉碎成药粉;
(2)将猪鬃草、猫须草、穿破石、威灵仙、楮实子、黄芪、黄花倒水莲、五指毛桃、牛膝、柴胡、麻黄粉粹成药材粗粉;向所述药材粗粉加入6倍重量的酒精度数为18%的甜酒水,混匀得混悬液,浸泡24小时后煎煮2次,每次2小时,合并药液,加入薄荷煮沸7分钟,过滤,取滤液浓缩成浸膏,将浸膏和步骤(1)得到的金沙牛,石龙子,水蛭,蝼蛄药粉混合均匀,湿法制粒,干燥,整粒,即得颗粒剂。用于患者口服,每次一处方量,一日3次,15日一疗程。
实施例3
处方:金沙牛3g、石龙子3g、水蛭3g、蝼蛄3g、柴胡5g、麻黄3g、猪鬃草30g、薄荷30g、猫须草30g、穿破石10g、威灵仙10g、楮实子10g、黄芪20g、黄花倒水莲20g、五指毛桃20g、牛膝10g。
制法:(1)将金沙牛、水蛭、石龙子和蝼蛄烘干粉碎成药粉;
(2)将猪鬃草、猫须草、穿破石、威灵仙、楮实子、黄芪、黄花倒水莲、五指毛桃、牛膝、柴胡、麻黄粉粹成药材粗粉;向所述药材粗粉加入3倍重量的酒精度数为15%的甜酒水,混匀得混悬液,浸泡24小时后煎煮1次,每次1小时,合并药液,加入薄荷煮沸5分钟,过滤,取滤液浓缩成浸膏,将浸膏和步骤(1)得到的金沙牛,石龙子,水蛭,蝼蛄药粉混合均匀,烘干后制成颗粒,装入胶囊。每个胶囊装药量为0.2g。用于患者口服,每次8粒,每天3次。
实施例4
处方:金沙牛5g、石龙子5g、水蛭5g、蝼蛄5g、柴胡10g、麻黄5g、猪鬃草40g、薄荷40g、猫须草40g、穿破石15g、威灵仙15g、楮实子15g、黄芪30g、黄花倒水莲30g、五指毛桃30g、牛膝15g。
制法(1)将金沙牛、水蛭、石龙子和蝼蛄烘干粉碎成药粉;
(2)将猪鬃草、猫须草、穿破石、威灵仙、楮实子、黄芪、黄花倒水莲、五指毛桃、牛膝、柴胡、麻黄粉粹成药材粗粉;向所述药材粗粉加入7倍重量的酒精度数为20%的甜酒水,混匀得混悬液,浸泡24小时后煎煮3次,每次3小时,合并药液,加入薄荷煮沸5分钟,过滤,取滤液浓缩成浸膏,将浸膏和步骤(1)得到的金沙牛,石龙子,水蛭,蝼蛄药粉混合均匀,湿法制粒,干燥,整粒,压片,即得片剂。每片重0.2g,用于患者口服,每次6片,每天3次。
实施例5
处方:金沙牛8g、石龙子8g、水蛭8g、蝼蛄8g、柴胡15g、麻黄8g、猪鬃草50g、薄荷50g、猫须草50g、穿破石20g、威灵仙20g、楮实子20g、黄芪40g、黄花倒水莲40g、五指毛桃40g、牛膝20g。
制法(1)将金沙牛、水蛭、石龙子和蝼蛄烘干粉碎成药粉;
(2)将猪鬃草、猫须草、穿破石、威灵仙、楮实子、黄芪、黄花倒水莲、五指毛桃、牛膝、柴胡、麻黄粉粹成药材粗粉;向所述药材粗粉加入10倍重量的酒精度数为16%的甜酒水,混匀得混悬液,浸泡24小时后煎煮3次,每次3小时,合并药液,加入薄荷煮沸10分钟,过滤,取滤液浓缩成浸膏,将浸膏和步骤(1)得到的金沙牛,石龙子,水蛭,蝼蛄药粉混合均匀,湿法制粒,干燥,整粒,压片,包衣,即得糖衣片。片心重0.2g,用于患者口服,每次5片,每天3次。
实验例1本发明中药组合物治疗泌尿系结石的疗效
临床实验中,选定400例泌尿系结石(石淋)患者,年龄18~55岁,平均年龄为29岁,随机分组,治疗组4组(分别为实施例2~5组),每组100例。
诊断依据为中华人民共和国中医药行业标准《中医病证诊断疗效标准》(ZY/T001.1-94):(1)发作时腰腹绞痛,痛及前阴,面色苍白,冷汗,恶心呕吐,可伴有发热恶寒,小便涩痛频急,或有排尿中断;(2)肉眼可见血尿,或小便有砂石排出;(3)尿常规检查有红细胞;(4)作肾系B超检查,或X线腹部平片、肾盂造影等可明确结石部位。必要时作膀胱镜逆行造影。
治疗方法:治疗组分别使用本发明实施例2~5制备的中药制剂,用于患者口服,每次一处方量,一日3次,15日一疗程。
疗效评定:(1)治愈:砂石排出,症状消失,X线摄片结石阴影消失。(2)有效:症状改善,X线摄片结石缩小或部位下移。(3)无效:症状及X线检查结石无变化。
经2个疗程后,治疗结果如表1所示:
表1实施例2~5治疗泌尿系结石的疗效
结论:本发明组方攻补兼备,标本兼治,动植物结合,升降同用,疗效高,无副作用,具有疗效好、见效快、无副作用、治疗成本低、制备方法简单的优点。
病案举例:
一,李某,52岁,工人,2015年夏就诊。尿痛、尿中断,伴小腹疼痛两周多。到某医院经X线膀胱平片示:“耻骨联合上方偏左有黄豆在小密度增高阴影,耻骨联合中间有多个密度增高阴。”拟诊为膀胱及后尿道结石。初服通淋排石药20多剂无效。后转给我诊,证见形瘦神疲,时有尿意,舌淡少苔,脉细软无力。考虑到病人年过半百,体气正衰,服用实施例1治疗后排出绿豆大小结石2粒,后继服5剂症状全部消失,经X线片复查致密影消失。继服六味地黄丸调理善后。
二,陈某,40岁,商人,2017年秋初诊。右侧腰腹疼痛,伴小便不畅已2日。到某医院经X线腹部平片诊断为“尿道结石”。症见病人腰腹疼痛,小便滴沥不畅,头昏疲乏,气短懒言,脉虚无力。证为气虚无力输送,至使无力排尿石。服用实施例2治疗后,当晚小便畅快,腰腹疼痛消失。
三,谢某,70岁,农民,2016年7月3日就诊。右上腹绞痛,伴尿涩痛1日。经腹部X线平片和双肾B超检查显示“右肾盂输尿管处有1.2cm×0.8cm卵圆形结石阴影,伴右肾盂积水”。现症见:右侧腰腹部疼痛及按痛,年老体弱,面色苍白,形塞肢冷,舌质淡暗,苔白,脉沉细。证属气虚血瘀结石阻滞。服用实施例2一个疗程后疼痛缓解,继服一个疗程症状全无,复查X线腹部平片结石阴影消失。后用济生肾气丸调理善后。
四,韦某,女,25岁,学生,2015年8月16日初诊。反复小便淋沥涩痛等症,经治缓解;此后偶尔因情志不遂而发作,静脉滴注抗生素可缓解。1周前因与人发生口角又病,静滴先锋霉素效果不佳。现症:尿涩尿痛,色黄,腰背痛,脘腹胀痛,易疲劳,舌苔腻,脉缓。B超提示:双肾结石直径0.5cm强光团伴声影。证脉合参,证属肝气郁滞,气化不利,蒸液成石。服用实施例3一个疗程后,诸症皆除,舌脉正常,B超提示:未见结石。停药观察,随访2年未见复发。
五,李某,男,56岁,农民,2016年4月3日初诊。反复腰痛10年,加重1个多月,伴排尿困难3日。病人于10年前曾发生右肾绞痛,先后排出结石9颗,今年3月以发生右腰绞痛,X线摄片诊为双肾结石、右输尿管多发性结石,右肾及右输尿管积水。症见口干欲饮,舌红苔少,脉弦细。证属湿热下注,膀胱气化不利,煎尿液,酿成结石。古人有“升清可以降浊”,“欲降必先升之”之说,服用实施例4两个疗程后,升其清气,降其浊瘀,使三焦的气机得以上下通畅,经查X线腹部平片,结石已经溶化消失。
六,杨某,男,52岁,干部,2017年1月5日初诊。腰痛4年,迭经中西医治疗未效,面部虚浮,失眠乏力,多次尿血,经医院造影、摄片,两侧肾盂输尿管积水(结石引起),尿检:红细胞(+++),白细胞(少许),蛋白(+),苔薄微腻,脉弦细。辨证属湿热蕴结下焦,凝而为石,阻塞气化,水液蓄潴,治宜化湿清热,利水通淋,服用实施例5一个疗程后,排出3枚结石,面浮腰痛随之好转,原方继服一个疗程,诸症消失,B超检查均恢复正常。嘱以六味地黄丸善后。
七,张某某,女,26岁,干部。2016年12月21日因左侧腰部剧痛10小时入院。入院后曾服左氧氟沙星胶囊及颅通定效果不佳。现疼痛依然,小便短赤,不能平卧,恶心肢厥,冷汗出,舌红苔薄黄,脉弦紧。腹部X片和B超均提示右肾盂结石伴积水(结石约0.5cm×0.3cm)。服用实施例5一个疗程后临床症状消失。经X片及B超复查正常。继用六君子汤调理善后。
八,陈某某,35岁,农民,2017年1月6日初诊。以右腰绞痛引少腹尿频尿痛,淋沥不尽伴尿血就诊,经X片诊为输尿管及膀胱结石。用上方加白茅根20克,水煎服,服用实施例2一个疗程后症状消失,B超检查恢复正常。继用壮腰健肾丸调理善后。
九,刘某某,47岁,自由工作者,2016年1月5日初诊。有结石手术史。现突发性一侧剧烈腹痛,疼痛向患侧下腹部、外阴部或大腿内侧放射,并伴有恶心、呕吐。化验检查可见肉眼血尿,或镜下血尿。B超检查显示均有不同程度的肾积水、输尿管扩张。确诊为肾结石复发引起的输尿管梗阻。服实施例3,1~2天后疼痛明显缓解,排尿通畅,5天后B超检查肾积水明显减少,输尿管扩张明显好转,继续服用14剂药后,临床症状均消失,舌脉、化验和B超检查均恢复正常。嘱服济生肾气丸善后。
十,韦某某,56岁,建筑工人,2017年1月5日初诊。因腰骶部痛1月,有时小便不畅,加重2天为主诉就诊,每因劳累后出现腰骶压痛明显,近2天来小腹疼痛加重,在当地治疗无好转。诊见腰骶部明显压痛,舌质黯红,苔微腻,舌根有瘀点,脉弦滑。B超检查膀胱结石,膀胱内可见数个强回光点,大者为0.4cm×0.7cm,确诊为膀胱结石。证属温热内蕴,煎成膀胱结石。经服用实施例4,3天后,肾部胀痛减轻,7天后减症状缓解,继服13天后症状消失,B超检查结石全消。
上述说明是针对本发明较佳可行实施例的详细说明,但实施例并非用以限定本发明的专利申请范围,凡本发明所提示的技术精神下所完成的同等变化或修饰变更,均应属于本发明所涵盖专利范围。
Claims (8)
1.一种治疗泌尿系结石的中药组合物,其特征在于,由下述原料组分制备而成:金沙牛、石龙子、水蛭、蝼蛄、柴胡、麻黄、猪鬃草、薄荷、猫须草、穿破石、威灵仙、楮实子、黄芪、黄花倒水莲、五指毛桃、牛膝。
2.根据权利要求1所述的中药组合物,其特征在于,由下述原料组分制备而成:金沙牛3~8重量份、石龙子3~8重量份、水蛭3~8重量份、蝼蛄3~8重量份、柴胡5~15重量份、麻黄3~8重量份、猪鬃草30~50重量份、薄荷30~50重量份、猫须草30~50重量份、穿破石10~20重量份、威灵仙10~20重量份、楮实子10~20重量份、黄芪20~40重量份、黄花倒水莲20~40重量份、五指毛桃20~40重量份、牛膝10~20重量份。
3.根据权利要求1或2所述的中药组合物,其特征在于,由下述原料组分制备而成:金沙牛5重量份、石龙子5重量份、水蛭5重量份、蝼蛄5重量份、柴胡10重量份、麻黄5重量份、猪鬃草40重量份、薄荷40重量份、猫须草40重量份、穿破石15重量份、威灵仙15重量份、楮实子15重量份、黄芪30重量份、黄花倒水莲30重量份、五指毛桃30重量份、牛膝15重量份。
4.权利要求1~3任一项所述中药组合物的制备方法,其特征在于,包括以下步骤:
(1)将金沙牛、水蛭、石龙子和蝼蛄烘干粉碎成药粉;
(2)将猪鬃草、猫须草、穿破石、威灵仙、楮实子、黄芪、黄花倒水莲、五指毛桃、牛膝、柴胡、麻黄用甜酒水浸泡,然后煎煮1~3次,每次1~3小时;合并药液,加入薄荷煮沸5~10分钟,过滤;取滤液浓缩成浸膏,将浸膏和步骤(1)得到的金沙牛,石龙子,水蛭,蝼蛄药粉混合均匀,即得。
5.根据权利要求4所述的制备方法,其特征在于,步骤(2)中,先将猪鬃草、猫须草、穿破石、威灵仙、楮实子、黄芪、黄花倒水莲、五指毛桃、牛膝、柴胡、麻黄粉粹成药材粗粉;向所述药材粗粉加入3~10倍重量的甜酒水,混匀得混悬液,浸泡24小时后煎煮3次,每次1小时,合并药液,加入薄荷煮沸5~10分钟,过滤,取滤液浓缩成浸膏,将浸膏和步骤(1)得到的金沙牛,石龙子,水蛭,蝼蛄药粉混合均匀,即得。
6.根据权利要求4或5所述的制备方法,其特征在于,所述甜酒水的酒精度数为15%~20%。
7.一种治疗泌尿系结石的中药制剂,其特征在于,由权利要求4或5所述方法制备得到的中药组合物和药学上可接受的载体组成。
8.权利要求4或5任一项所述方法制备的中药组合物或权利要求7所述的制剂在制备治疗泌尿系结石药物中的应用。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810776856.6A CN110772565A (zh) | 2018-07-13 | 2018-07-13 | 一种治疗泌尿系结石的中药组合物及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810776856.6A CN110772565A (zh) | 2018-07-13 | 2018-07-13 | 一种治疗泌尿系结石的中药组合物及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN110772565A true CN110772565A (zh) | 2020-02-11 |
Family
ID=69377168
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201810776856.6A Pending CN110772565A (zh) | 2018-07-13 | 2018-07-13 | 一种治疗泌尿系结石的中药组合物及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN110772565A (zh) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1324639A (zh) * | 2000-05-23 | 2001-12-05 | 周竟森 | 治疗泌尿系结石的药物 |
CN1939437A (zh) * | 2005-09-29 | 2007-04-04 | 张春华 | 一种治疗肾结石的药物 |
CN103920033A (zh) * | 2014-04-10 | 2014-07-16 | 李恩东 | 用于治疗结石的中药组合物 |
CN107875312A (zh) * | 2017-12-08 | 2018-04-06 | 武宣县中医院 | 一种治疗肾结石的中药制剂及其制备方法 |
-
2018
- 2018-07-13 CN CN201810776856.6A patent/CN110772565A/zh active Pending
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1324639A (zh) * | 2000-05-23 | 2001-12-05 | 周竟森 | 治疗泌尿系结石的药物 |
CN1939437A (zh) * | 2005-09-29 | 2007-04-04 | 张春华 | 一种治疗肾结石的药物 |
CN103920033A (zh) * | 2014-04-10 | 2014-07-16 | 李恩东 | 用于治疗结石的中药组合物 |
CN107875312A (zh) * | 2017-12-08 | 2018-04-06 | 武宣县中医院 | 一种治疗肾结石的中药制剂及其制备方法 |
Non-Patent Citations (4)
Title |
---|
峻;陈铭;黄坚;: "崔学教诊治泌尿系结石经验撷萃" * |
沈其仰: "四金排石散治疗泌尿系结石75例" * |
翟本超;: "自拟金威汤治疗泌尿系结石36例" * |
谭海川;: "自拟胆石汤治疗胆石症45例" * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103656535B (zh) | 一种治疗高脂血症的中药组合物及其制备方法 | |
CN104740222A (zh) | 一种治疗白癜风的中药 | |
CN101721528B (zh) | 一种治疗慢性前列腺炎的药物组合物 | |
CN102698207A (zh) | 一种治疗肝病的中药组合物及其制备方法 | |
CN103341092A (zh) | 一种治疗萎缩性阴道炎的散剂制备方法 | |
CN104547961B (zh) | 一种治疗胆结石的中药组合物 | |
CN103028071B (zh) | 用于治疗腹泻型肠易激综合征的中药组合物及其制备方法 | |
CN102805834B (zh) | 一种治疗胃炎的药物及其制备方法 | |
CN112870286B (zh) | 治疗特应性皮炎的中药组合物、制备方法及其应用 | |
CN103301353A (zh) | 一种治疗萎缩性阴道炎的药物组合物 | |
CN110772565A (zh) | 一种治疗泌尿系结石的中药组合物及其制备方法 | |
CN104825991A (zh) | 一种用于酒精中毒性精神障碍的中药制剂及制备方法 | |
CN104189362A (zh) | 一种用于治疗口腔癌的药物及制备方法 | |
CN104491316B (zh) | 一种治疗中气不足型前列腺增生症的中药制剂 | |
CN106256372A (zh) | 一种治疗慢性前列腺炎的内服药物及其制备方法 | |
CN108721422B (zh) | 一种用于霉菌性阴道炎治疗的药物组合物及其制备方法 | |
CN104623387A (zh) | 一种用于治疗慢性肾炎的药物组合物 | |
CN119896704A (zh) | 一种快速治愈口腔溃疡的中药组合物及其制备方法 | |
CN104740157A (zh) | 一种治疗小儿哮喘的中药组合物 | |
CN105412452A (zh) | 一种治疗暑湿感冒的足浴+洗浴保健中药 | |
CN104645233A (zh) | 一种治疗乳腺增生的中药制剂 | |
CN104491312A (zh) | 中药制剂在制备治疗前列腺炎、前列腺肥大药物中的用途 | |
CN104001044A (zh) | 一种治疗高脂血症的中药组合物 | |
CN104208291A (zh) | 一种治疗热淋的中药制剂及其制备方法 | |
CN104740396A (zh) | 治疗肾结石的中药剂及制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20200211 |